PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21325253-1	2011	This study evaluated the activity of tigecycline combined with imipenem, amikacin, and ciprofloxacin against clinical isolates of multidrug-resistant Klebsiella pneumoniae and Escherichia coli co-producing extended-spectrum beta-lactamases and acquired AmpC beta-lactamases.	Tigecycline	37-48	beta-lactamase	Escherichia coli	253-257	
18077630-0	2008	Treatment with tigecycline of recurrent urosepsis caused by extended-spectrum-beta-lactamase-producing Escherichia coli.	Tigecycline	15-26	beta-lactamase	Escherichia coli	78-92	
32364269-7	2021	All AmpC and/or ESBL-phenotype E. coli were sensitive to colistin, ertapenem, imipenem, meropenem, temocillin and tigecycline, applying epidemiological cut-off values.	Tigecycline	114-125	beta-lactamase	Escherichia coli	4-8